Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Sinobioway Medicine(002581) the Revenue is 50.17 M (+41.56%);the EBIT is -57.41 M (-9.49%);the EPS is -0.0625 (-35.55%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.05B41.56%
----
----
EBIT
-0.06B9.49%
----
----
EPS
-0.062535.55%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf